Federal Register / Vol. 90, No. 3 / Monday, January 6, 2025 / Notices 653 

One (1) seat for a representative of an 

independent assessment service will be 

appointed for a three year term. 

Applications for membership on the 

Committee will be accepted until 5 p.m. 

eastern standard time on Monday, 

January 20, 2025. 

There are two parts to submitting an 

application. First, complete the 

information requested via this electronic 

form https://forms.gle/ 

Aezt29xYzqy7Q4gv5. Next, email your 

CV or resume and a letter of 

endorsement from your organization or 

organization’s leadership, endorsing you 

to represent your company, in .PDF 

format to fscac@gsa.gov with the subject 

line: FSCAC APPLICATION— 

[Applicant Name]. The letter of 

endorsement must come from your 

organization or organization’s 

leadership. If you are the CEO, then it 

must come from another member of the 

executive team of your organization, as 

you cannot endorse yourself. The letter 

must be signed and specifically state 

that you are authorized to apply to 

FSCAC as a representative of your 

organization. 

Applications that do not include the 

completion of the above instructions 

will not be considered. 

Letters of Recommendation may also 

be submitted if desired by the applicant; 

however, please note they may or may 

not have an impact on final 

appointments and are not required for 

an application to be considered. 

Margaret Dugan, 

Service-Level Liaison, Federal Acquisition 

Service, General Services Administration. 

[FR Doc. 2024–31554 Filed 1–3–25; 8:45 am] 

BILLING CODE 6820–34–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2021–N–0403] 

Food Contact Notifications That Are 

No Longer Effective 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA or we) is 

announcing its determination that the 

Food Contact Notifications (FCNs) listed 

in this notice are no longer effective. 

Several manufacturers notified FDA in 

writing that they ceased producing, 

supplying, or using the listed food 

contact substances (FCSs) for their 

intended use in the United States. We 

are taking this action in accordance with 

the process set out in our regulations, by 

which FDA may determine that an FCN 

is no longer effective. 

DATES: Applicable date: This 

determination for the FCNs listed in 

table 1 and table 2 is effective January 

6, 2025. 

Compliance date: June 30, 2025, is the 

compliance date for the FCSs listed in 

table 2 that were produced, supplied, or 

used by the manufacturer or supplier 

prior to the effective date of this 

determination. 

ADDRESSES: For access to the docket to 

read background documents or 

comments received go to https://

www.regulations.gov and insert the 

docket number found in brackets in the 

heading of this document into the 

‘‘Search’’ box and follow the prompts, 

and/or go to the Dockets Management 

Staff, 5630 Fishers Lane, Rm. 1061, 

Rockville, MD 20852. 

FOR FURTHER INFORMATION CONTACT: 

Lillian Mawby, Office of Food Chemical 

Safety, Dietary Supplements, and 

Innovation, Human Foods Program, 

Food and Drug Administration, 5001 

Campus Dr., College Park, MD 20740, 

301–796–4041 or Carrol Bascus, Office 

of Policy, Regulations and Information, 

Human Foods Program, Food and Drug 

Administration, 5001 Campus Dr., 

College Park, MD 20740, 240–402–2378. 

SUPPLEMENTARY INFORMATION: 

I. Background 

In the Federal Register of March 22, 

2024 (89 FR 20306), FDA issued a final 

rule to amend its regulations at 

§ 170.105 (21 CFR 170.105) to provide 

additional reasons, other than safety, 

that may form the basis to determine 

that an FCN is no longer effective. One 

reason we may determine that an FCN 

is no longer effective is when the 

manufacturer or supplier has ceased or 

will cease the production, supply, or 

use of the food contact substance for its 

intended use authorized by the FCN 

(referred to as ‘‘abandonment’’). 

Several manufacturers or suppliers 

notified FDA, through voluntary 

commitment letters (Ref. 1), that they 

have ceased producing, supplying, or 

using authorized FCSs for their 

intended food contact use in the United 

States. FDA received this information 

before issuing the final rule. After the 

final rule’s effective date of May 21, 

2024, consistent with 

§ 170.105(a)(2)(ii)(A), we contacted the 

manufacturers or suppliers to inform 

them that their voluntary commitment 

letters demonstrate that they had 

ceased, and did not intend to resume in 

the future, producing, supplying, or 

using the subject FCSs for their 

intended food contact use. We provided 

the manufacturers or suppliers an 

opportunity to respond and did not 

receive any responses that disagreed 

with our findings. Therefore, in 

accordance with § 170.105(a)(2)(ii)(B), 

we determined that the FCNs are no 

longer effective based on abandonment. 

This notice constitutes the detailed 

summary of the basis for FDA’s 

determination that these specific FCNs 

are no longer effective in accordance 

with § 170.105(b). 

Tables 1 and 2 identify FCNs that are 

no longer effective, as well as the FCSs 

no longer authorized by these FCNs, as 

of the publication date of this notice. 

Based on the end of sales dates provided 

by the manufacturers for the FCSs listed 

in FCNs in table 1, we expect any 

existing stocks of these FCSs to have 

already been exhausted from the U.S. 

market. For the FCSs listed in the FCNs 

in table 2, we are providing a 

compliance date for existing stocks of 

products that were produced, supplied, 

or used by the manufacturer or supplier 

before January 6, 2025. Based on the 

information provided in the voluntary 

commitment letter from that 

manufacturer, we expect any existing 

stocks of these products to be exhausted 

by June 30, 2025. We have determined 

that providing a compliance date of June 

30, 2025, to exhaust these existing 

stocks would be protective of public 

health. For this reason, in accordance 

with § 170.105(b) we are establishing a 

compliance date of June 30, 2025, for 

the use of FCSs listed in table 2 in food 

contact articles if the FCSs were 

produced, supplied, or used by the 

manufacturer or supplier before January 

6, 2025. 

TABLE 1—FOOD CONTACT NOTIFICATIONS (FCNS) NO LONGER EFFECTIVE AS OF JANUARY 6, 2025 

FCN No. FCS Manufacturer/supplier 

59 ................ Glycine, N,N-bis[2-hydroxy-3-(2-propenyloxy)propyl]-, monosodium salt, reaction products with ammonium hydroxide and pentafluoroiodoethane-tetrafluoroethylene telomer (CAS Reg. No. 220459–70–1).BASF Corporation. 


khammond on DSK9W7S144PROD with NOTICES
654 Federal Register / Vol. 90, No. 3 / Monday, January 6, 2025 / Notices 

TABLE 1—FOOD CONTACT NOTIFICATIONS (FCNS) NO LONGER EFFECTIVE AS OF JANUARY 6, 2025—Continued 

FCN No. FCS Manufacturer/supplier 

187 .............. Fluorinated polyurethane anionic resin (CAS Reg. No. 328389–91–9) prepared by reacting perfluoropolyether 

diol (CAS Reg. No. 88645–29–8), isophorone diisocyanate (CAS Reg. No. 4098–71–9), 2,2- 

dimethylolpropionic acid (CAS Reg. No. 4767–03–7), and triethylamine (CAS Reg. No. 121–44–8).

Solvay Specialty Polymers Italy 

S.p.A. 

195 .............. Diphosphoric acid, polymers with ethoxylated reduced Me esters of reduced polymerized oxidized tetrafluoroethylene (CAS Reg. No. 200013–65–6). This substance is also known as: phosphate esters of ethoxylated 

perfluoroether, prepared by reaction of ethoxylated perfluoroether diol (CAS Reg. No. 162492–15–1) with 

phosphorous pentoxide (CAS Reg. No. 1314–56–3) or pyrophosphoric acid (CAS Reg. No. 2466–09–3).

Solvay Specialty Polymers Italy 

S.p.A. 

206 .............. Copolymer of 2-perfluoroalkylethyl acrylate, 2-N,N-diethylaminoethyl methacrylate, and glycidyl methacrylate ... DuPont Chemical Solutions Enterprise. 

255 .............. 3-cyclohexane-1-carboxylic acid, 6-((di-2-propenylamino)carbonyl)-,(1R,6R), reaction products with 

pentafluoroiodoethane-tetrafluoroethylene telomer, ammonium salts.

BASF Corporation. 

311 .............. Copolymers of 2-perfluoroalkylethyl acrylate, 2-N,N-diethylaminoethyl methacrylate, and glycidyl methacrylate .. DuPont Chemical Solutions Enterprise. 

314 .............. 2-Propen-1-ol, reaction products with pentafluoroiodoethane-tetrafluoroethylene telomer, dehydroiodinated, reaction products with epichlorohydrin and triethylenetetramine (CAS Reg. No. 464178–90–3).Solenis LLC. 

338 .............. Copolymers of 2-perfluoroalkylethyl acrylate, 2-N,N-diethylaminoethyl methacrylate, and glycidyl methacrylate .. DuPont Chemical Solutions Enterprise. 

398 .............. Perfluoropolyether dicarboxylic acid (CAS Reg. No. 69991–62–4), ammonium salt .............................................. Solvay Specialty Polymers Italy 

S.p.A. 

416 .............. Diphosphoric acid, polymers with ethoxylated reduced methyl esters of reduced polymerized oxidized tetrafluoroethylene (CAS Reg. No. 200013–65–6). This substance is also known as phosphate esters of 

ethoxylated perfluoroether, prepared by reaction of ethoxylated perfluoroether diol (CAS Reg. No. 162492– 

15–1) with phosphorous pentoxide (CAS Reg. No. 1314–56–3) or pyrophosphoric acid (CAS Reg. No. 

2466–09–3).

Solvay Specialty Polymers Italy 

S.p.A. 

487 .............. 2-propen-1-ol, reaction products with pentafluoroiodoethane-tetrafluoroethylene telomer, dehydroiodinated, reaction products with epichlorohydrin and triethylenetetramine (CAS Reg. No. 464178–90–3).Solenis LLC. 

518 .............. 2-propen-1-ol, reaction products with pentafluoroiodoethane-tetrafluoroethylene telomer, dehydroiodinated, reaction products with epichlorohydrin and triethylenetetramine (CAS Reg. No 464178–90–3).Solenis LLC. 

538 .............. Perfluoropolyether dicarboxylic acid (CAS Reg. No. 69991–62–4), ammonium salt .............................................. Solvay Specialty Polymers Italy 

S.p.A. 

542 .............. 2-propen-1-ol, reaction products with 1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluoro-6-iodohexane, dehydroiodinated, reaction products with epichlorohydrin and triethylenetetramine (CAS Reg. No. 464178–94–7).Solenis LLC. 

628 .............. Copolymer of 2-perfluoroalkylethyl acrylate, 2-(dimethylamino)ethyl methacrylate, and oxidized 2- 

(dimethylamino)ethyl methacrylate (CAS Reg. No. 479029–28–2).

Clariant Corporation. 

646 .............. Copolymers of 2-perfluoroalkylethyl acrylate, 2-N,N-diethylaminoethyl methacrylate, glycidyl methacrylate, 

acrylic acid, and methacrylic acid (CAS Reg. No. 870465–08–0).

Dupont Chemical Solutions Enterprise. 

746 .............. 2-propen-1-ol, reaction products with 1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluoro-6-iodohexane, dehydroiodinated, reaction products with epichlorohydrin and triethylenetetramine (CAS Reg. No. 464178–94–7) as manufactured in accordance with the description in the FCN.Solenis LLC. 

783 .............. 2-propen-1-ol, reaction products with 1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluoro-6-iodohexane, dehydroiodinated, reaction products with epichlorohydrin and triethylenetetramine (CAS Reg. No. 464178–94–7) as manufactured in accordance with the description in the FCN.Solenis LLC. 

820 .............. 2-Propenoic acid, 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl ester, polymer with a-(1-oxo-2-propen-1-yl)-whydroxypoly(oxy-1,2-ethanediyl).Daikin America, Inc. 

827 .............. 2-propenoic acid, 2-hydroxyethyl ester, polymer with a-(1-oxo-2-propen-1-yl)-w-hydroxypoly(oxy-1,2- 

ethanediyl), a-(1-oxo-2-propen-1-yl)-w-[(1-oxo-2-propen-1-yl)oxy]poly(oxy-1,2-ethanediyl) and 

3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl 2-propenoate (CAS Reg. No. 1012783–70–8).

Daikin America, Inc. 

885 .............. 2-propenoic acid, 2-methyl-, polymer with 2-(diethylamino)ethyl 2-methyl-2-propenoate, 2-propenoic acid and 

3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl 2-methyl-2-propenoate, acetate (CAS Reg. No. 1071022–26–8).

The Chemours Company FC, LLC. 

888 .............. 2-propenoic acid, 2-hydroxyethyl ester, polymer with a-(1-oxo-2-propen-1-yl)-w-hydroxypoly(oxy-1,2- 

ethanediyl), a-(1-oxo-2-propen-1-yl)-w-[(1-oxo-2-propen-1-yl)oxy]poly(oxy-1,2-ethanediyl) and 

3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl 2-propenoate (CAS Reg. No. 1012783–70–8).

Daikin America, Inc. 

933 .............. 2-propenoic acid, 2-methyl-, polymer with 2-hydroxyethyl 2-methyl-2-propenoate, a-(1-oxo-2-propen-1-yl)-whydroxypoly(oxy-1,2-ethanediyl) and 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl 2-propenoate sodium salt 

(CAS Reg. No. 1158951–86–0).

Daikin America, Inc. 

940 .............. Hexane, 1,6-diisocyanato-, homopolymer, 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanol-blocked (CAS Reg. 

No. 357624–15–8).

The Chemours Company FC, LLC. 

962 .............. Diphosphoric acid, polymers with ethoxylated reduced methyl esters of reduced polymerized oxidized tetrafluoroethylene (CAS Reg. No. 200013–65–6). This substance is also known as phosphate esters of 

ethoxylated perfluoroether, prepared by reaction of ethoxylated perfluoroether diol (CAS Reg. No. 162492– 

15–1) with phosphorous pentoxide (CAS Reg. No. 1314–56–3) or pyrophosphoric acid (CAS Reg. No. 

2466–09–3).

Solvay Specialty Polymers USA, 

LLC. 

1027 ............ 2-propenoic acid, 2-methyl-, polymer with 2-(diethylamino)ethyl 2-methyl-2-propenoate, 2-propenoic acid and 

3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl 2-methyl-2-propenoate, acetate (CAS Reg. No. 1071022–26–8).

The Chemours Company FC, LLC. 

1044 ............ 2-propenoic acid, 2-methyl-, 2-hydroxyethyl ester polymer with 1-ethyenyl-2-pyrrolidinone, 2-propenoic acid 

and 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl 2-propenoate sodium salt (CAS Reg. No. 1206450–10–3).

Daikin America, Inc. 

1097 ............ Hexane, 1,6-diisocyanato-, homopolymer, a-[1-[[[3-[[3 (dimethylamino)propyl]amino]propyl]amino]carbonyl]- 

1,2,2,2-tetrafluoroethyl]-w-(1,1,2,2,3,3,3-heptafluoropropoxy)poly[oxy[trifluoro(trifluoromethyl)-1,2-ethanediyl]]- 

blocked (CAS Reg. No. 1279108–20–1).

Archroma U.S., Inc. 

1360 ............ 2-Propenoic acid, 2-methyl-, 2-(dimethylamino)ethyl ester, polymer with 1-ethenyl-2-pyrrolidinone and 

3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl 2-propenoate, acetate (CAS Reg. No. 1334473–84–5).

Daikin America, Inc. 

1451 ............ 2-Propenoic acid, 2-methyl-, 2-(dimethylamino)ethyl ester, polymer with 1-ethenyl-2-pyrrolidinone and 

3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl 2-propenoate, acetate (CAS Reg. No. 1334473–84–5).

Daikin America, Inc. 

1493 ............ Copolymer of 2-(dimethylamino) ethyl methacrylate with 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl methacrylate, N-oxide, acetate (CAS Reg. 1440528–04–0).Archroma Management GmbH. 


khammond on DSK9W7S144PROD with NOTICES
Federal Register / Vol. 90, No. 3 / Monday, January 6, 2025 / Notices 655 

TABLE 2—FOOD CONTACT NOTIFICATIONS (FCNS) NO LONGER EFFECTIVE AS OF JANUARY 6, 2025 WITH A COMPLIANCE

DATE OF JUNE 30, 2025 

FCN No. FCS Manufacturer/supplier 

599 .............. Copolymer of perfluorohexylethyl methacrylate, 2-N,N-diethylaminoethyl methacrylate, 2-hydroxyethyl methacrylate, and 2,2’-ethylenedioxydiethyl dimethacrylate, acetic acid salt (CAS Reg. No. 863408–20–2) or 

malic acid salt (CAS Reg. No. 1225273–44–8).

Asahi Glass Co., Ltd. (Manufacturer) 

and AGC Chemicals Americas, Incorporated. 

604 .............. Copolymer of perfluorohexylethyl methacrylate, 2-N,N-diethylaminoethyl methacrylate, 2-hydroxyethyl methacrylate, and 2,2’-ethylenedioxydiethyl dimethacrylate, acetic acid salt (CAS Reg. No. 863408–20–2) or 

malic acid salt (CAS Reg. No. 1225273–44–8).

Asahi Glass Co., Ltd. (Manufacturer) 

and AGC Chemicals Americas, Incorporated. 

1186 ............ Butanedioic acid, 2-methylene-, polymer with 2-hydroxyethyl, 2-methyl-2-propenoate, 2-methyl-2-propenoic 

acid and 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl 2-methyl-2-propenoate, sodium salt (CAS Reg. No. 

1345817–52–8).

Asahi Glass Co., Ltd. 

AGC Chemicals Americas, Inc. 

1676 ............ 2-propenoic acid, 2-methyl-, 2-hydroxyethyl ester, polymer with 2-propenoic acid and 3,3,4,4,5,5,6,6,7,7,8,8,8-

tridecafluorooctyl 2-methyl-2-propenoate, sodium salt (CAS Reg. No. 1878204–24–0).

Asahi Glass Co., Ltd. 

AGC Chemicals Americas, Inc. 

To reflect these changes in status of 

the affected FCNs, we established an 

Inventory of Food Contact Notifications 

That are No Longer Effective on FDA’s 

website. The Inventory may be viewed 

at https://www.hfpappexternal.fda.gov/ 

scripts/fdcc/index.cfm?set=FCN-nolonger-effective. 

We also updated our Inventory of 

Effective Food Contact Notifications 

accordingly at https://www.hfpapp

external.fda.gov/scripts/fdcc/ 

index.cfm?set=FCN. 

A food additive is deemed unsafe 

unless that substance and its use 

conform with a regulation issued under 

section 409 of the Federal Food, Drug, 

and Cosmetic Act (FD&C Act) (21 U.S.C. 

348) or there is an FCN submitted under 

section 409(h) of the FD&C Act that is 

effective (section 409(a) of the FD&C 

Act). An effective FCN is specific only 

to the intended use of the substance 

prepared by the manufacturer or 

supplier identified in the FCN (section 

409(h)(1)(C)). 

Our determination that an FCN is no 

longer effective does not preclude any 

manufacturers or suppliers from 

submitting a new FCN for the same FCS, 

including for the same intended use, 

after FDA has determined that an FCN 

is no longer effective, unless the 

intended use of the FCS is authorized by 

a food additive regulation or the subject 

of an issued threshold of regulation 

exemption, per 21 CFR 170.105(c). 

II. Analysis of Environmental Impact 

We have determined under 21 CFR 

25.32(m) that this action is of a type that 

does not individually or cumulatively 

have a significant effect on the human 

environment. Therefore, neither an 

environmental assessment nor an 

environmental impact statement is 

required. 

III. References 

The following references are on 

display at the Dockets Management 

Staff, (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, Rm. 

1061, Rockville, MD 20852, 240–402– 

7500 and are available for viewing by 

interested persons between 9 a.m. and 4 

p.m., Monday through Friday; they also 

are available electronically at https://

www.regulations.gov. Although FDA has 

verified the website addresses in this 

document, please note that websites are 

subject to change over time. 

1. FDA, Market Phase-Out of Grease-Proofing 

Substances Containing PFAS, 

Commitment Letters from Industry 

available at: https://www.fda.gov/food/ 

process-contaminants-food/marketphase-out-grease-proofing-substancescontaining-pfas. 

Dated: December 30, 2024. 

P. Ritu Nalubola, 

Associate Commissioner for Policy. 

[FR Doc. 2024–31692 Filed 1–3–25; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2024–N–5889] 

Request for Nominations of Voting 

Members on a Public Advisory 

Committee; National Mammography 

Quality Assurance Advisory 

Committee 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is requesting 

nominations for voting members to 

serve on the National Mammography 

Quality Assurance Advisory Committee 

in the Center for Devices and 

Radiological Health. Nominations will 

be accepted for current and upcoming 

vacancies effective February 1, 2025, 

with this notice. FDA seeks to include 

the views of women and men, members 

of all racial and ethnic groups, and 

individuals with and without 

disabilities on its advisory committees 

and, therefore, encourages nominations 

of appropriately qualified candidates 

from these groups. 

DATES: Nominations received on or 

before March 7, 2025, will be given first 

consideration for membership on the 

National Mammography Quality 

Assurance Advisory Committee. 

Nominations received after March 7, 

2025, will be considered for nomination 

to the committee as later vacancies 

occur. 

ADDRESSES: All nominations for 

membership should be submitted 

electronically by logging into the FDA 

Advisory Nomination Portal at https://

www.accessdata.fda.gov/scripts/ 

FACTRSPortal/FACTRS/index.cfm or by 

mail to Advisory Committee Oversight 

and Management Staff, Food and Drug 

Administration, 10903 New Hampshire 

Ave., Bldg. 32, Rm. 5103, Silver Spring, 

MD 20993–0002. Information about 

becoming a member on an FDA advisory 

committee can also be obtained by 

visiting FDA’s website at https://

www.fda.gov/AdvisoryCommittees/ 

default.htm. 

FOR FURTHER INFORMATION CONTACT: 

Regarding all nomination questions for 

membership: James P. Swink, Center for 

Devices and Radiological Health, Food 

and Drug Administration, 10903 New 

Hampshire Ave., Bldg. 66, Rm. 5211, 

Silver Spring, MD 20993, 301–796– 

6313, James.Swink@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: FDA is 

requesting nominations for voting 

members to fill upcoming vacancies on 

the National Mammography Quality 

Assurance Advisory Committee. 

I. General Description of the Committee 

Duties 

The National Mammography Quality 

Assurance Advisory Committee advises 

the Commissioner of Food and Drugs 

(the Commissioner) or designee on: (1) 

developing appropriate quality 

standards and regulations for 

mammography facilities; (2) developing 

appropriate standards and regulations 


khammond on DSK9W7S144PROD with NOTICES